BLISSGVS

HealthcareDrug Manufacturers - Specialty & GenericMid Cap
Bliss GVS Pharma Limited

Bliss GVS Pharma Limited, operating in the Healthcare sector as a Drug Manufacturer - Specialty & Generic, engages in the development, manufacturing, and marketing of pharmaceutica...

हिन्दी में

ब्लिस जीवीएस फार्मा लिमिटेड, हेल्थकेयर क्षेत्र में एक ड्रग मैन्युफैक्चरर - स्पेशलिटी एंड जेनेरिक के रूप में कार्यरत है, फार्मास्युटिकल फॉर्मूलेशन के विकास, निर्माण और विपणन में संल...

₹681.55+0.75%1D
Previous trading day close · Data updates after market close
1W: -1.9%
1M: -1.4%
6M: +169.9%
1Y: +345.5%
67/100
AverageResearch Score
Market Cap
₹5.2K Cr
Mid Cap
P/E Ratio
54.09
Premium
P/B Ratio
6.04
Premium
ROE
11.1%
Weak
ROCE
15.4%
Good
Debt / Equity
0.02
Low debt
Div. Yield
0.2%
EV/EBITDA
36.57
Expensive
52W Low: ₹118Current: ₹681.5552W High: ₹739.9
At 91% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
74/100
Growth
Revenue, EPS, profit growth
76/100
Valuation
PE, PB, EV/EBITDA vs sector
38/100
Risk
Debt levels, volatility, coverage
89/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
54.09(Premium)
Forward P/E
N/A
P/B Ratio
6.04(Premium)
P/S Ratio
7.21(Expensive)
EV/EBITDA
36.57(Expensive)
Dividend Yield
0.2%
5Y CAGR
36.0%(High growth)
Revenue Growth
37.6%(High)
Profitability
ROE
11.1%(Average)
ROCE
15.4%(Good)
ROA
9.2%(Average)
Net Margin
13.5%(Decent)
EBITDA Margin
24.6%
Financial Health
Debt to Equity
0.02(Low debt)
Current Ratio
4.02(Healthy)
Quick Ratio
3.38(Good)
Interest Coverage
52.10x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
50(Neutral)
RSI Exp (14)
44(Neutral)
MACD
19.934(Bullish)
MACD Signal
28.863
BB Position
34%(Middle)
BB Width
10.95%(Normal)
ADX (14)
18.7(Sideways)
Williams %R
-66.0(Neutral)
MFI (14)
74(Neutral)
CCI (20)
-77(Neutral)
Stoch %K
34(Neutral)
ATR (14)
33.31(Avg True Range)
OBV (M)
424.1(Positive)
1W OBV Chg
-0.1%(Decreasing)
Rel Volume
0.45x(Low activity)
Volatility
58.7%(High)
Max DD 1Y
-37.3%(Moderate)
Alpha (CAPM)
366.40%(Outperforming Nifty)
Return vs Nifty
362.7%(Beating Nifty)
EMA 200
422.4
EMA 50
618.5
SMA 200
368.4
vs SMA 50
13.0%(Above SMA50)
vs SMA 200
85.0%(Above SMA200)
Volume
1.67L
Avg Vol 3M
3.7L
Shareholding Pattern
Promoter
35.4%
Low stake
FII
10.4%
DII / MF
5.0%
Share BLISSGVS
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.